NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Atara’

17 December 2013

Amgen Ventures joins KPCB, others backing $38.5m Series B for drug developer Atara

Thrasos Therapeutics kidney - AltAssets Private Equity News Amgen Ventures is among the new investors committing capital to drug development company Atara Therapeutics as part of a $38.5m Series B financing round.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014